Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice
Stefania Tognin, Hendrika H van Hell, Kate Merritt, Inge Winter-van Rossum, Matthijs G Bossong, Matthew J Kempton, Gemma Modinos, Paolo Fusar-Poli, Andrea Mechelli, Paola Dazzan, Arija Maat, Lieuwe de Haan, Benedicto Crespo-Facorro, Birte Glenthoj, Stephen M Lawrie, Colm McDonald, Oliver Gruber, Therese van Amelsvoort, Celso Arango, Tilo Kircher Show all
SCHIZOPHRENIA BULLETIN | OXFORD UNIV PRESS | Published : 2020
In the last 2 decades, several neuroimaging studies investigated brain abnormalities associated with the early stages of psychosis in the hope that these could aid the prediction of onset and clinical outcome. Despite advancements in the field, neuroimaging has yet to deliver. This is in part explained by the use of univariate analytical techniques, small samples and lack of statistical power, lack of external validation of potential biomarkers, and lack of integration of nonimaging measures (eg, genetic, clinical, cognitive data). PSYSCAN is an international, longitudinal, multicenter study on the early stages of psychosis which uses machine learning techniques to analyze imaging, clinical,..View full abstract
Awarded by European Union's Seventh Framework Programme
The PSYSCAN Project is supported by grant agreement no. 603196 under the European Union's Seventh Framework Programme.